CEP
IMMU

Chicago Equity Partners’s Immunomedics Inc IMMU Stock Holding History

Chicago Equity Partners’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-57,225
Closed -$1.21M – 940
2019
Q4 		$1.21M Buy
+57,225
New +$1.01M 0.07% 399
2018
Q1 		– Sell
-43,350
Closed -$701K – 837
2017
Q4 		$701K Sell
43,350
-279,970
-87% -$3.3M 0.02% 564
2017
Q3 		$4.52M Buy
323,320
+81,060
+33% +$808K 0.14% 205
2017
Q2 		$2.14M Sell
242,260
-121,495
-33% -$853K 0.06% 358
2017
Q1 		$2.35M Buy
363,755
+127,700
+54% +$647K 0.07% 287
2016
Q4 		$866K Buy
236,055
+30,710
+15% +$90.9K 0.02% 488
2016
Q3 		$667K Buy
205,345
+94,285
+85% +$264K 0.02% 508
2016
Q2 		$258K Buy
+111,060
New +$371K 0.01% 581

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Chicago Equity Partners's IMMU Position: Q1 2020 in Review

Chicago Equity Partners sold out of Immunomedics Inc (IMMU) in Q1 2020, closing a stake of 57,225 shares — an estimated $1.21M sold.

Chicago Equity Partners first reported a position in IMMU in Q2 2016 and held it in 8 quarters. The position peaked at $4.52M in Q3 2017. 220 funds tracked by Wall St. Rank hold IMMU as of Q1 2020.

  • Chicago Equity Partners reported no remaining Immunomedics Inc position as of Q1 2020 after selling out during the quarter.
  • Chicago Equity Partners sold 57,225 Immunomedics Inc shares in Q1 2020, an estimated $1.21M.
  • Chicago Equity Partners first reported a position in Immunomedics Inc in Q2 2016 and held it in 8 quarters.
  • Chicago Equity Partners's Immunomedics Inc position peaked at $4.52M in Q3 2017.
  • 220 funds tracked by Wall St. Rank held Immunomedics Inc as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.